Goldman Sachs Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $46

Benzinga ·  May 13 11:50

Goldman Sachs analyst Corinne Jenkins maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $53 to $46.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment